Free Trial

Inari Medical (NARI) News Today

Inari Medical logo
$50.56 +1.32 (+2.68%)
(As of 11/15/2024 ET)
Inari Medical, Inc. stock logo
Inari Medical (NASDAQ:NARI) Stock Price Up 4.3% - What's Next?
Inari Medical (NASDAQ:NARI) Trading Up 4.3% - Here's Why
Inari Medical, Inc. stock logo
Aigen Investment Management LP Takes Position in Inari Medical, Inc. (NASDAQ:NARI)
Aigen Investment Management LP acquired a new position in shares of Inari Medical, Inc. (NASDAQ:NARI - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 10,369 shares of the company's stock, valued at approx
Inari Medical, Inc. stock logo
Inari Medical, Inc. (NASDAQ:NARI) Shares Sold by Fiera Capital Corp
Fiera Capital Corp lessened its stake in Inari Medical, Inc. (NASDAQ:NARI - Free Report) by 3.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 563,567 shares of the company's stock after selling 19,821
Inari Medical, Inc. stock logo
Financial Enhancement Group LLC Takes Position in Inari Medical, Inc. (NASDAQ:NARI)
Financial Enhancement Group LLC acquired a new stake in Inari Medical, Inc. (NASDAQ:NARI - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 28,002 shares of the company's stock, valued at approximately $1,15
Inari Medical, Inc. stock logo
William Blair Boosts Earnings Estimates for Inari Medical
Inari Medical, Inc. (NASDAQ:NARI - Free Report) - Equities researchers at William Blair upped their FY2025 EPS estimates for Inari Medical in a report issued on Thursday, October 31st. William Blair analyst M. Kaczor now anticipates that the company will post earnings per share of $0.18 for the y
Inari Medical (NARI) Receives a Hold from Stifel Nicolaus
Inari Medical, Inc. stock logo
Leerink Partnrs Expects Increased Earnings for Inari Medical
Inari Medical, Inc. (NASDAQ:NARI - Free Report) - Investment analysts at Leerink Partnrs boosted their Q4 2024 earnings per share estimates for Inari Medical in a research report issued to clients and investors on Monday, October 28th. Leerink Partnrs analyst M. Kratky now forecasts that the comp
Inari Medical, Inc. stock logo
FY2026 EPS Estimates for Inari Medical Decreased by Analyst
Inari Medical, Inc. (NASDAQ:NARI - Free Report) - Research analysts at Leerink Partnrs reduced their FY2026 earnings per share (EPS) estimates for Inari Medical in a report issued on Monday, October 28th. Leerink Partnrs analyst M. Kratky now anticipates that the company will post earnings of $0.
Inari Medical reports PEERLESS study met primary composite endpoint
Key Takeaways From Inari Medical Analyst Ratings
Inari Medical price target raised to $50 from $46 at Truist
Inari Medical: Record Revenue, but Loss
Inari Medical, Inc. stock logo
Inari Medical (NASDAQ:NARI) Given New $50.00 Price Target at Truist Financial
Truist Financial raised their price target on shares of Inari Medical from $46.00 to $50.00 and gave the company a "hold" rating in a report on Tuesday.
Inari Medical, Inc. stock logo
Inari Medical (NASDAQ:NARI) Shares Gap Up After Analyst Upgrade
Inari Medical (NASDAQ:NARI) Shares Gap Up After Analyst Upgrade
Inari Medical, Inc. stock logo
Inari Medical (NASDAQ:NARI) Receives Hold Rating from Needham & Company LLC
Needham & Company LLC reaffirmed a "hold" rating on shares of Inari Medical in a report on Tuesday.
Inari Medical: A $4 Billion Opportunity Is Wide Open
Inari Medical, Inc. (NARI)
Inari Medical's Earnings: A Preview
Inari Medical, Inc. stock logo
Inari Medical, Inc. (NASDAQ:NARI) Given Consensus Recommendation of "Hold" by Analysts
Shares of Inari Medical, Inc. (NASDAQ:NARI - Get Free Report) have been given a consensus rating of "Hold" by the eleven brokerages that are currently covering the firm, MarketBeat.com reports. Six research analysts have rated the stock with a hold recommendation and five have assigned a buy recom
Inari Medical’s Artix 2.0 receives FDA approval, says BofA
Okami Medical Announces Closing Of $32.5M Financing
Inari Medical, Inc. stock logo
Inari Medical, Inc. (NASDAQ:NARI) Director Sells $1,800,800.00 in Stock
Inari Medical, Inc. (NASDAQ:NARI - Get Free Report) Director William Hoffman sold 40,000 shares of the business's stock in a transaction dated Wednesday, October 16th. The stock was sold at an average price of $45.02, for a total transaction of $1,800,800.00. Following the sale, the director now directly owns 601,233 shares of the company's stock, valued at $27,067,509.66. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Inari Medical, Inc. stock logo
Leerink Partnrs Lowers Earnings Estimates for Inari Medical
Inari Medical, Inc. (NASDAQ:NARI - Free Report) - Research analysts at Leerink Partnrs dropped their Q3 2024 earnings per share (EPS) estimates for shares of Inari Medical in a report issued on Tuesday, October 15th. Leerink Partnrs analyst M. Kratky now expects that the company will earn ($0.13)
Abbott Laboratories (ABT) Gets a Buy from Piper Sandler
Inari Medical, Inc. stock logo
Inari Medical, Inc. (NASDAQ:NARI) Forecasted to Earn Q2 2025 Earnings of ($0.01) Per Share
Inari Medical, Inc. (NASDAQ:NARI - Free Report) - Analysts at Leerink Partnrs cut their Q2 2025 earnings per share estimates for shares of Inari Medical in a research note issued on Tuesday, October 15th. Leerink Partnrs analyst M. Kratky now anticipates that the company will earn ($0.01) per sha
Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial
Inari Medical, Inc. stock logo
SG Americas Securities LLC Acquires Shares of 15,144 Inari Medical, Inc. (NASDAQ:NARI)
SG Americas Securities LLC purchased a new position in shares of Inari Medical, Inc. (NASDAQ:NARI - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 15,144 shares of the company's stock, valued
Inari Medical, Inc. stock logo
Inari Medical (NASDAQ:NARI) Price Target Cut to $46.00
Truist Financial cut their price target on Inari Medical from $55.00 to $46.00 and set a "hold" rating for the company in a report on Monday.
Inari Medical, Inc. stock logo
Inari Medical's (NARI) "Hold" Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC reaffirmed a "hold" rating on shares of Inari Medical in a research report on Wednesday.
Get Inari Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NARI and its competitors with MarketBeat's FREE daily newsletter.

Let’s be blunt (Ad)

Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!

Check out the $100 Challenge now

NARI Media Mentions By Week

NARI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NARI
News Sentiment

1.19

0.55

Average
Medical
News Sentiment

NARI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NARI Articles
This Week

4

9

NARI Articles
Average Week

Get Inari Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NARI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:NARI) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners